Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
In 40-50% of patients with essential hypertension, a high sodium intake does not increase renal blood flow (RBF). These patients have been defined as nonmodulators because sodium intake does not modulate renal and adrenal responsiveness to angiotensin II (AII). To define the role of AII in mediating...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1985
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425457/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2985655/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111828 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
